David J. Haydon

Technik-/Wissenschafts-/F&E-Leiter bei Prolysis Ltd.

Health Technology

Profil

David J.
Haydon is Manager of Drug Development for Prolysis Ltd.
Prior to joining Prolysis in 2003, he worked at Oxford GlycoSciences Plc.
Dr. Haydon has research experience in the microbial genetics and biochemistry field.
He holds a PhD.

Aktive Positionen von David J. Haydon

Unternehmen	Position	Beginn
Prolysis Ltd. Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2003

Alle aktiven Positionen von David J. Haydon

Ehemalige bekannte Positionen von David J. Haydon

Unternehmen	Position	Ende
Oxford GlycoSciences Plc Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von David J. Haydon im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David J. Haydon im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Prolysis Ltd. Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK.	Health Technology
Oxford GlycoSciences Plc Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.	Health Technology